Literature DB >> 18342621

Inhibition of histone deacetylase1 induces autophagy.

Meeyeon Oh1, In-Kwon Choi, Ho Jeong Kwon.   

Abstract

Autophagy is a process where cytoplasmic materials are degraded by lysosomal machinery. Histone deacetylase (HDAC) inhibitors induce autophagy, and HDAC6, one of class II HDAC isotypes, is directly involved in autophagic degradation in the cell. However, it is unclear if class I HDAC isotype such as HDCA1 is involved in this process. To investigate if class I HDAC isotype is involved in autophagy, a specific class I HDAC inhibitor and an siRNA of HDAC1 were used to treat HeLa cells. Autophagic markers were then investigated. Both inhibition and genetic knock-down of HDAC1 in the cells significantly induced autophagic vacuole formation and lysosome function. Moreover, disruption of HDAC1 leads to the conversion of LC3-I to LC3-II. Together, these results demonstrate that HDAC1 could play a role in autophagy and specific inhibition of HDAC1 can induce autophagy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18342621     DOI: 10.1016/j.bbrc.2008.03.019

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  42 in total

Review 1.  Epigenetic therapy of lymphoma using histone deacetylase inhibitors.

Authors:  Maribel Cotto; Fernando Cabanillas; Maribel Tirado; María V García; Eileen Pacheco
Journal:  Clin Transl Oncol       Date:  2010-06       Impact factor: 3.405

Review 2.  The return of the nucleus: transcriptional and epigenetic control of autophagy.

Authors:  Jens Füllgrabe; Daniel J Klionsky; Bertrand Joseph
Journal:  Nat Rev Mol Cell Biol       Date:  2013-12-11       Impact factor: 94.444

3.  Antitumor activity of SAHA, a novel histone deacetylase inhibitor, against murine B cell lymphoma A20 cells in vitro and in vivo.

Authors:  Bohan Yang; Dandan Yu; Jingwen Liu; Kunyu Yang; Gang Wu; Hongli Liu
Journal:  Tumour Biol       Date:  2015-02-04

4.  Inhibition of autophagy induced by TSA sensitizes colon cancer cell to radiation.

Authors:  Gang He; Yan Wang; Xueli Pang; Bo Zhang
Journal:  Tumour Biol       Date:  2014-02

5.  Distinct and redundant functions of histone deacetylases HDAC1 and HDAC2 in proliferation and tumorigenesis.

Authors:  Jennifer Jurkin; Gordin Zupkovitz; Sabine Lagger; Reinhard Grausenburger; Astrid Hagelkruys; Lukas Kenner; Christian Seiser
Journal:  Cell Cycle       Date:  2011-02-01       Impact factor: 4.534

Review 6.  Autophagy as a therapeutic target in cardiovascular disease.

Authors:  Andriy Nemchenko; Mario Chiong; Aslan Turer; Sergio Lavandero; Joseph A Hill
Journal:  J Mol Cell Cardiol       Date:  2011-06-23       Impact factor: 5.000

Review 7.  The emerging role of acetylation in the regulation of autophagy.

Authors:  Agnes Bánréti; Miklós Sass; Yacine Graba
Journal:  Autophagy       Date:  2013-03-06       Impact factor: 16.016

Review 8.  Redox biology and the interface between bioenergetics, autophagy and circadian control of metabolism.

Authors:  Adam R Wende; Martin E Young; John Chatham; Jianhua Zhang; Namakkal S Rajasekaran; Victor M Darley-Usmar
Journal:  Free Radic Biol Med       Date:  2016-05-27       Impact factor: 7.376

9.  A new synthetic HDAC inhibitor, MHY218, induces apoptosis or autophagy-related cell death in tamoxifen-resistant MCF-7 breast cancer cells.

Authors:  Ji Hye Park; Mee Young Ahn; Tae Hyung Kim; Sungpill Yoon; Keon Wook Kang; Jaewon Lee; Hyung Ryong Moon; Jee H Jung; Hae Young Chung; Hyung Sik Kim
Journal:  Invest New Drugs       Date:  2011-10-08       Impact factor: 3.850

10.  Combination of proteasome and HDAC inhibitors for uterine cervical cancer treatment.

Authors:  Zhenhua Lin; Martina Bazzaro; Mei-Cheng Wang; Kwun C Chan; Shiwen Peng; Richard B S Roden
Journal:  Clin Cancer Res       Date:  2009-01-15       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.